Obstetrics & Gynecology · Kittanning, PA
NPI
1881738870
Since 2007
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
500 Medical Arts Bldg, Suite 540
Kittanning, PA, 16201
Phone (724) 543-8378
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,006
90 services
Medicare patients, 2024
65
Average age 70
Drug cost, 2024
$89K
1,025 prescriptions
Company payments, 2025
$648
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey W David was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 53 times for 53 patients. In total Jeffrey W David billed 90 services in 12 codes, and Medicare paid $4,006.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 53 | 53 | $38.08 | $2,019 |
| 99213 Office E&M - Established | Office | 15 | 12 | $70.92 | $1,064 |
By year: 2022 $3,409 for 70 services; 2023 $4,759 for 75 services; 2024 $4,006 for 90 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey W David prescribed most often to Medicare patients was Alendronate Sodium, with 181 prescriptions and refills. In total Jeffrey W David wrote 1,025 Medicare prescriptions that cost $89K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alendronate Sodium Generic | 181 | 236 | 31 | $952 |
| Raloxifene Hcl Generic | 118 | 160 | 20 | $3,080 |
| Estradiol (Twice Weekly) Estradiol | 111 | 160 | 19 | $9,275 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 66 | 86 | 12 | $1,834 |
| Estradiol (Once Weekly) Estradiol | 58 | 94 | 11 | $4,368 |
| Dotti Estradiol | 46 | 62 | Under 11 | $4,090 |
| Estradiol Generic | 45 | 74 | 13 | $3,423 |
| Myrbetriq Mirabegron | 35 | 47 | Under 11 | $21K |
| Medroxyprogesterone Acetate Generic | 29 | 61 | Under 11 | $395 |
| Norethindrone Acetate Generic | 26 | 38 | Under 11 | $549 |
| Ibuprofen Generic | 23 | 23 | 14 | $144 |
| Yuvafem Estradiol | 23 | 27 | Under 11 | $1,602 |
| Oxybutynin Chloride Generic | 22 | 34 | Under 11 | $240 |
| Premarin Estrogens, Conjugated | 20 | 39 | Under 11 | $7,172 |
| Solifenacin Succinate Generic | 19 | 31 | Under 11 | $651 |
Brand drugs: 207 claims; generic drugs: 818 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey W David $648 ($648 in general payments such as food, travel and fees) from 13 companies. The largest payer was Sage Therapeutics, LLC with $179.
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC SAGE | 7 | $179 |
| Millicent US Inc | 4 | $74.67 |
| Supernus Pharmaceuticals, Inc. SUPN | 3 | $69.33 |
| Pfizer Inc. PFE | 4 | $64.3 |
| Amgen Inc. AMGN | 3 | $53.47 |
| Mayne Pharma Commercial LLC | 2 | $39.46 |
| Organon LLC OGN | 2 | $34.46 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $30.87 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $29.83 |
| Cumberland Pharmaceuticals, Inc. CPIX | 1 | $23.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.